# Ajay Mahipal

> Ajay Mahipal is a Series B investor at HealthQuad (New Delhi) backing Health Care and Software. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [HealthQuad](https://shizune.co/investors/profile/healthquads)
- Location: New Delhi, India
- Total investments: 6
- Last investment: Apr 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ajaymahipal
- Facebook: https://www.facebook.com/ajay.mahipal.3

Ajay Mahipal is a Series B investor at HealthQuad in New Delhi focused on Health Care and Software. Ajay Mahipal is based out of New Delhi and is the Co-Founder and Partner of HealthKois. Ajay previously worked at Frontizo as a Board Member. Ajay Mahipal attended Indian Institute of Management Lucknow.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 67% |
| Software | 2 | 33% |
| Wellness | 2 | 33% |
| Machine Learning | 2 | 33% |
| Fitness | 1 | 17% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Series C | 2 | 33% |
| Funding Round | 1 | 17% |
| Post-IPO Equity | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ekincare | ekincare is a patent-pending AI-powered integrated health benefits platform helping organizations and Employees with a Preventive, Predictive and Highly Personalised Healthcare solution.Trusted by many fortune 500 companies ekincare redefines healthcare by being India's first personal health assistant using technology, analytics, andcurated services.Our integrated platform provides access to a multitude of online and offline healthcare services such as 24*7 chat with a doc, health check-ups, medicines purchase and delivery, Health coach programs, Mental wellness programs, Gyms & Fitness services, etc |  | Series C | Apr 29, 2025 |  |
| Beta Drugs | Beta Drugs is a drug delivery system that differentiates itself and increases patient compliance. They promote patient compliance, are simple to use, prevent dosing mistakes, and reduce drug waste. They create and market sophisticated oncology medications. | $13.9M | Post-IPO Equity | Nov 28, 2024 |  |
| BeatO | BeatO, short for beat diabetes (the 'O' being the ring of diabetes), is a mobile platform that motivates a diabetic to increase compliance and reduce their out of pocket expense. Their small and nimble health and tech focused team comprises top talent that brings in the passion and desire to roll out the best user experience for adiabetic in managing their ailment. In their core team (tech & business), we have Type 1 and Type 2 diabetics, with real life practical know-how of diabetes and how to beat it. | $33M | Series B | Nov 16, 2022 |  |
| Qure AI | At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. | $40M |  | Mar 30, 2022 |  |
| Qure AI | At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. | $40M | Series C | Mar 29, 2022 |  |
| ekincare | ekincare is a patent-pending AI-powered integrated health benefits platform helping organizations and Employees with a Preventive, Predictive and Highly Personalised Healthcare solution.Trusted by many fortune 500 companies ekincare redefines healthcare by being India's first personal health assistant using technology, analytics, andcurated services.Our integrated platform provides access to a multitude of online and offline healthcare services such as 24*7 chat with a doc, health check-ups, medicines purchase and delivery, Health coach programs, Mental wellness programs, Gyms & Fitness services, etc | $15M | Series B | Mar 17, 2022 |  |

6 of 6 investments shown.

## Co-investors
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 3 deals together
- [MassMutual Ventures](https://shizune.co/investors/profile/massmutual-ventures) — VC Fund, 2 deals together
- [W Health Ventures](https://shizune.co/investors/profile/w-health-ventures) — VC Fund, 2 deals together
- [Alteria Capital](https://shizune.co/investors/profile/alteria-capital) — VC Fund, 1 deal together
- [Lightrock india (Aspada)](https://shizune.co/investors/profile/aspada) — VC Fund, 1 deal together
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund, 1 deal together

## About HealthQuad

VC Fund · Mehrauli, India

HealthQuad’s investment philosophy is to create value by empowering visionary entrepreneurs building unique solutions that have the potential to redefine the way the society prevents and treats illness. Their approach is defined by “inspired ownership” and they strive to act as a meaningful strategic partner and not just as a financial sponsor.They provide a platform where entrepreneurs can work with us to get not only the capital but also the advice, support, and tools they need to achieve their market potential. In the eyes of the entrepreneurs, they see that the breadth and depth of their expertise, their strong network and their rich ecosystem, are their raison d’être for partnering with us.

5 contacts available at HealthQuad.

| Name | Title | Profile |
| --- | --- | --- |
| Ajay Mahipal | Director | https://shizune.co/investors/profile/ajay-mahipal |
| Abrar Mir | Co-Founder & Advisor | https://shizune.co/investors/profile/abrar-mir |
| Amit Varma | Co-Founder & Advisor | https://shizune.co/investors/profile/amit-varma-4773 |
| Charles-Antoine Janssen | Co-Founder and Chief Investment Officer | https://shizune.co/investors/profile/charles-antoine-janssen-92f4 |
| Charles-Antoine Janssen | Co-Founder and Chief Investment Officer | https://shizune.co/investors/profile/charles-janssen |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ajay Mahipal invest in?

Ajay Mahipal invests primarily in Health Care, Software and Wellness startups, most often at Series B and Series C stage. Most of the 6 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ajay Mahipal last invest?

The most recent investment recorded for Ajay Mahipal closed in Apr 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co